HAMED KAMAL bought SPRO
February 1, 2024 · Form 4 insider transaction
HAMED KAMAL bought 239,731 shares of Spero Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
239,731
Price
$0.00
Total value
N/A
InsiderHAMED KAMAL
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 1, 2024
Filing dateFebruary 5, 2024
Shares owned after816,192
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on February 1, 2025, subject to the Reporting Person's continued service through the applicable vesting date.